“The efficacy of administering elbasvir/grazoprevir as hepatitis C therapy in hemodialysis patients with comorbid of hypertension and diabetes mellitus”, Udayana In. Med., vol. 7, no. 2, pp. 35–38, Dec. 2023, doi: 10.36216/jpd.v7i2.228.